{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-030245","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2023-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.547026+00:00","generated_at":"2026-06-11T03:32:03.536996+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"BriaCell gets court approval for spin-out of BriaPro Therapeutics, effective Aug 31, 2023","bullets":["Court approved spin-out of BriaPro Therapeutics with pipeline assets including Bria-TILsRx and PKCδ inhibitors.","Effective date expected August 31, 2023; SpinCo to be ~2/3 owned by BriaCell and ~1/3 by BriaCell shareholders.","Shareholders receive one SpinCo share and one new BriaCell share for each old share held.","BriaCell remains listed on Nasdaq and TSX; SpinCo to be unlisted reporting issuer in Canada."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-030245","json":"https://secwatch.observer/filing/0001493152-23-030245.json","markdown":"https://secwatch.observer/filing/0001493152-23-030245.md","text":"https://secwatch.observer/filing/0001493152-23-030245.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315223030245/0001493152-23-030245-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315223030245/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T03:32:03.536996+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}